Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N D Maynard

Showing results (21-30 of 24) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 24 results.
The British Journal of Surgery|May 19, 2017
Metabolic nodal response as a prognostic marker after neoadjuvant therapy for oesophageal cancerJ M Findlay, K M Bradley, L M Wang, et al.
BJS Open|August 26, 2020
Impact on postoperative complications of changes in skeletal muscle mass during neoadjuvant chemotherapy for gastro-oesophageal cancerR B den Boer, K I Jones, S Ash, et al.
Scientific Reports|May 10, 2018
Translational study identifies XPF and MUS81 as predictive biomarkers for oxaliplatin-based peri-operative chemotherapy in patients with esophageal adenocarcinomaT P MacGregor, R Carter, R S Gillies, et al.
Diseases of the Esophagus : Official Journal of the International Society for Diseases of the Esophagus|November 1, 2017
A comparison of the left thoracoabdominal and Ivor-Lewis esophagectomyA R Davies, J Zylstra, C R Baker, et al.
Pageof 3

Showing results (21-30 of 24) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 24 results.
The British Journal of Surgery|May 19, 2017
Metabolic nodal response as a prognostic marker after neoadjuvant therapy for oesophageal cancerJ M Findlay, K M Bradley, L M Wang, et al.
BJS Open|August 26, 2020
Impact on postoperative complications of changes in skeletal muscle mass during neoadjuvant chemotherapy for gastro-oesophageal cancerR B den Boer, K I Jones, S Ash, et al.
Scientific Reports|May 10, 2018
Translational study identifies XPF and MUS81 as predictive biomarkers for oxaliplatin-based peri-operative chemotherapy in patients with esophageal adenocarcinomaT P MacGregor, R Carter, R S Gillies, et al.
Diseases of the Esophagus : Official Journal of the International Society for Diseases of the Esophagus|November 1, 2017
A comparison of the left thoracoabdominal and Ivor-Lewis esophagectomyA R Davies, J Zylstra, C R Baker, et al.
Pageof 3